Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Int J Pharm ; 623: 121962, 2022 Jul 25.
Artigo em Inglês | MEDLINE | ID: mdl-35764260

RESUMO

The efficient development of robust tableting processes is challenging due to the lack of mechanistic understanding on the impact of raw material properties and process parameters on tablet quality. The experimental determination of the effect of process and formulation parameters on tablet properties and subsequent optimization is labor-intensive, expensive and time-consuming. The combined use of an extensive raw material property database, process simulation tools and multivariate modeling allows more efficient and more optimized development of the direct compression (DC) process. In this study, key material attributes and in-process mechanical properties with a potential effect on tablet processability and tablet properties were identified. In a first step, an extensive characterization of 55 raw materials (over 100 material descriptors) (Van Snick et al., 2018) and 26 formulation blends (31 material descriptors) (Dhondt et al., 2022) was performed. These blends were subsequently compacted on a compaction simulator under multiple process conditions through a design of experiments (DoE) approach. A T-shaped partial least squares (T-PLS) model was established which correlates tablet quality attributes with process settings, raw material properties and blend ratios. During future development of the DC formulation and process for a new active pharmaceutical ingredient (API), this model can then be used to provide a preliminary formulation and compaction process settings as starting point to be further optimized during development trials based on well-defined raw material characteristics and compaction tests. This study hence contributes to a better understanding on the impact of raw material properties and process settings on a DC process and final properties of the produced tablets; and provides a platform allowing a more efficient and more optimized development of a robust tableting process.


Assuntos
Química Farmacêutica , Tecnologia Farmacêutica , Composição de Medicamentos , Análise dos Mínimos Quadrados , Pós , Pressão , Comprimidos
2.
Int J Pharm ; 621: 121801, 2022 Jun 10.
Artigo em Inglês | MEDLINE | ID: mdl-35526701

RESUMO

This study developed a material and time saving method for powder characterization. Building on an earlier developed raw material property database for use towards development of pharmaceutical dry powder processes, blends were selected in an efficient way to include maximal variability of the underlying raw material dataset. For both raw materials and blends, powder characterization methods were kept to a minimum by selecting the testing methods that described the highest amount of variability in physical powder properties based on principal component analysis (PCA). This method selection was made by identifying the overarching properties described by the principal components of the PCA model. Ring shear testing, powder bed compressibility, bulk/tapped density, helium pycnometry, loss on drying and aeration were identified as the most discriminating characterization techniques from this dataset to detect differences in physical powder properties. This ensured a workload reduction while most of the powder variability that could be detected was still included. The methodology proposed in this paper could be used as a material-saving alternative to the current "Design of Experiment" approach, which will be investigated further for applicability to speed up the development of formulations and processes for new drug products and building an end-to-end predictive platform.


Assuntos
Química Farmacêutica , Tecnologia Farmacêutica , Química Farmacêutica/métodos , Composição de Medicamentos , Desenvolvimento de Medicamentos , Tamanho da Partícula , Pós , Tecnologia Farmacêutica/métodos
3.
Int J Pharm ; 563: 122-134, 2019 May 30.
Artigo em Inglês | MEDLINE | ID: mdl-30951857

RESUMO

Manufacturability of active pharmaceutical ingredients (APIs) is often evaluated by an empirical approach during development due to limited material availability. This brings challenges in designing flexible yet robust manufacturing processes under highly accelerated timelines. Hence, good utilisation of a limited material dataset is key to accelerate the delivery of high quality final drug product into the market at minimum cost and maximum process capacity. In this study, we present a data-driven method to investigate a raw materials database where the integration of multivariate analysis and machine learning modelling aids the selection of new incoming materials based on their manufacturability. The procedure was applied to an industrial representative database of thirty-four APIs and seven excipients where eight measurements relevant to flow properties for each of those forty-one materials were collected. The models identified four clusters of materials with different flow properties. These models can serve as a risk assessment tool for new API in early product development phases based on the nearest surrogate material which behave similarly, as well as to identify targeted and material sparring experiments to address key risks during secondary process selection.


Assuntos
Desenvolvimento de Medicamentos , Modelos Teóricos , Bases de Dados Factuais , Excipientes/química , Tamanho da Partícula , Preparações Farmacêuticas/química , Reologia , Máquina de Vetores de Suporte , Propriedades de Superfície
4.
Int J Pharm ; 549(1-2): 415-435, 2018 Oct 05.
Artigo em Inglês | MEDLINE | ID: mdl-30118831

RESUMO

In current study a holistic material characterization approach was proposed and an extensive raw material property database was developed including a wide variety of APIs and excipients with different functionalities. In total 55 different materials were characterized and described by over 100 raw material descriptors related to particle size and shape distribution, specific surface area, bulk, tapped and true density, compressibility, electrostatic charge, moisture content, hygroscopicity, permeability, flowability and wall friction. Principal component analysis (PCA) was applied to reveal similarities and dissimilarities between materials and to identify overarching properties. The developed PCA model allows to rationalize the number of critical characterization techniques in routine characterization and to identify surrogates for use during early drug product development stages when limited amounts of active pharmaceutical ingredients are available. Additionally, the developed database will be the basis to build predictive models for in silico process and formulation development based on (a selection of) property descriptors.


Assuntos
Simulação por Computador , Excipientes/química , Modelos Químicos , Modelos Estatísticos , Preparações Farmacêuticas/química , Tecnologia Farmacêutica/métodos , Bases de Dados de Compostos Químicos , Fricção , Análise Multivariada , Tamanho da Partícula , Permeabilidade , Porosidade , Pós , Análise de Componente Principal , Água/química , Molhabilidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA